 |
 |
|
| |
The following is a list of events taking place at The Chemists' Club, or are events of general interest to our
members, and to professionals working in the Chemical and
related industries in the area. If your organization would
like to have an event at the Chemists' Club, or would like
your event listed on our web page, please send an email to
events@thechemistsclub.com.
|
Tuesday, Sep 23, 2008
- Sept 25, 2008 | Windhover's 18th Annual Pharmaceutical Strategic Alliances
Capturing Value: What business models are next for the biopharma world?
September 23-25, 2008
New York Marriott Downtown • New York City
It’s THE MOST senior level case studies for dealmaking and strategy available in the industry.
Windhover's 18th Annual Pharmaceutical Strategic Alliances is simply where you will meet the most important people in the business.
Our 2008 speaker lineup includes:
Martin Mackay
President, Pfizer Global Research & Development
Mervyn J. Turner PhD
Senior Vice President, Worldwide Licensing & External Research, Merck & Co.
Jeremy M. Levin
Senior Vice President, External Science, Tech. & Licensing, Bristol-Myers Squibb
Thomas Hofstaetter
Senior Vice President / Corporate Business Development, Wyeth
Ad Rawcliffe
Senior Vice President, Worldwide Business Development, GlaxoSmithkline
Even the optimists in the pharma and biotech worlds don’t see much future for business-models-as-usual. They may not agree on the model – but they agree that what we’ve got isn’t right. The 2008 PSA conference focuses on what’s next for the broader biopharma worlds – models that break down the walls between Big Pharma, biotech and spec pharma pipelines, and open up the financing opportunities to a much broader investment audience. PSA looks at these innovative ways of developing medicines and capturing value.
While Big Pharma struggles to think small, biotechs wrestle with how to get big – in value – without all that infrastructure.
So while Big Pharma tries to recreate biotech creativity, spins off research and products, cuts costs … biotech experiments with ways of dispensing with vertical interpretation. Is ripping apart the value chain the next step for both? As they do so, traditional pharmaceuticals will be at the very heart of the activity. You can follow – even shape – the actions at the industry’s most important strategy meeting: Pharmaceutical Strategic Alliances.
Maximize your strategic alliance opportunities by hearing CEOs, senior R&D and senior business development executives share lessons learned, practical advice and strategies on how to build your R&D pipeline – both internally and externally. Take away the newest strategies and tactics that you can apply to your company’s dealmaking efforts immediately!
And this September, PSA offers you an unbeatable line-up of Big Pharma and biotech speakers to forecast trends and analyze changes in alliances and M&A. You’ll hear from, and be able to quiz, top industry executives and dealmakers.
PSA gathers top thinkers to grapple with the fundamental challenges facing biotech and pharma – equipping dealmakers like you with the insights, information and practical advice you'll need to strike successful deals. This program will sell out so register early. Space is limited, so register today!
Pharmaceutical Strategic Alliances is going to explore the different strategies of externalization, from the podium and in the hallways, in a depth you will experience at no other conference because we have the speakers and the attendees who set the strategies.
| |
